精工鋼構(600496.SH):2021年擬申請授信額度為67.47億
格隆匯 3 月 19日丨精工鋼構(600496.SH)公佈,公司關於第七屆董事會2021年度第二次臨時會議決議,審議通過了《關於公司及控股子公司2021年度銀行授信的議案》;
根據公司及控股子公司2021年生產經營資金需要,公司擬申請授信額度為67.47億,其中流動資金借款及敞口銀票授信56.59億(新增主要為戰略及業務開展增加的併購貸款等),工程類保函授信10.88億。為確保融資需求,董事會提請股東大會授權公司董事長在授信額度內申請授信事宜,並同意其在借款行或新增銀行間可以調劑使用,授權期限自股東大會審議批准之日至下一年審批該事項股東大會召開之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.